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From 1985 to 1992, 193 children with tuberculous
meningitis (TBM) with a median age of 26 months were
admitted to the Department of Paediatrics and Child
Health, Tygerberg Hospital. Of these children 143 (74%)
were documented to have received BCG, either by
reference to 'Road to Health' cards or by contact with
local authority clinic staff. In a further 18 children a BCG
scar was visible. Therefore at least 161 of the children
(83%) had received BCG vaccination. As the Western
Cape has also been shown to have the highest incidence
of TBM in South Africa, there is concern that BCG as
currently used does not have a significant protective effect
against dissemfnated tuberculosis.
Seventy-seven children (40%) were also reported to
have a close household contact who had been treated for
pulmonary tuberculosis within the previous 24 months.
Only 17 of these children (22%), however, were prescribed
prophylactic isoniazid and only 7 of these completed 3
months or more prophylaxis.
S Atr Med J 1995; 85: 167-170.
Since its introduction in 1921, BCG has been the subject of
considerable controversy and acrimonious debate.'.2
Controlled trials of BCG vaccination have produced results
varying from an efficacy of 80% to a negative influence in
some instances, and these trials have been dogged by
variation in the epidemiological situation, the dose and strain
of BCG used, the manner of vaccination and age at
vaccination.' Despite the above problems, recent
assessments, usually by cas~ control studies, of the use of
neonatal BCG vaccination in developing countries have
consistently shown an efficacy of between 60% and 80% in
the prevention of disseminated forms of tuberculosis."?
Neonatal BCG vaccination has been carried out on a large
scale in South Africa since 1973 and is now given to more
than 90% of neonates in the area served by the Western
Cape Regional Services Council."
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Isoniazid chemoprophylaxis given to infected individuals
for at least 6 months is known to reduce the incidence of
SUbsequent tuberculous disease; this has been
substantiated in a number of clinical trials." However, non-
compliance is a recognised problem'o that considerably
reduces the efficacy of this measure.",12
In this paper we describe our further experience with the
BCG status of children presenting with tuberculous
meningitis (rBM) in the Western Cape and the failure to
implement isoniazid prophylaxis to prevent TBM in the close
contacts of adults with pUlmonary tuberculosis.
Methods
From 1985 to 1992, 193 children aged from 3 months to 154
months (median 26 months) with TBM were admitted to the
Department of Paediatrics and Child Health, Tygerberg
Hospital, for the management of raised intracranial pressure
and other complications." Aspects of the clinical
presentation and BCG status of 88 of the children seen
between 1985 and 1988 have been presented previously. 14
In 26 children (13%) the diagnosis of TBM was confirmed by
culture of Mycobacterium tuberculosis from cerebrospinal
fluid. In the remainder the diagnosis of probable TBM was
accepted and supported by one or more of the following:
(J) culture of M. tuberculosis from gastric aspirate in 15
children; VI) a chest radiograph compatible with the
diagnosis of primary tuberculosis in 91 children (47%); and
(iif) a Mantoux test that gave an induration of more than
15 mm in 87 children (45%).
The severity of neurological involvement on admission
was classified .on the basis of the British Medical Research
Council report of 1948." (J) stage I - these children were
fully conscious with signs of meningeal irritation only; (if)
stage 11 - these children were mentally confused and had,
in addition, cranial nerve palsies or hemiparesis; (iil) stage III
- these children were comatose or had complete
hemiplegia or, more rarely, quadriplegia.
The BCG status of the children was confirmed by
reference to 'Road to Health' cards or, when these were not
available, by the local authority clinic closest to the patients'
home address. In addition, children were examined for the
presence of a BCG scar on the right upper arm.
Parents or caretakers were questioned as to the presence
of close adult contacts with pulmonary tuberculosis in the
household and whether the children had been offered
chemoprophylaxis. Staff at the clinic nearest to the patients'
homes were again contacted to confirm that
chemoprophylaxis had indeed been given and to comment
on the degree of compliance achieved.
This study was approved by the Ethical Committee of the
Faculty of Medicine of the University of Stellenbosch.
Results
Eighty-five (44%) of the children were at stage III of the
disease on admission, 104 (54%) stage 11 and 4 (2%) at
stage I. In Fig. 1 the percentage of children presenting with
stage III TBM is illustrated in relation to age. Whereas 60%
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Table I. BCG status of children with tuberculous meningitis
close household contact compared with 37 (34%) of the 109
children aged 24 months or more. In 19 instances (25%) the
contact was a grandparent, and in 38 (49%) a parent; 7 of
the latter were said to have died of pulmonary tuberculosis.
Other family members or lodgers constituted the remaining
20 contacts several of whom had had contact with the child
in the capacity of 'child-minder', while the mother worked.
Eleven children had been in contact with more than one
adult with pulmonary tuberculosis.
Only 17 (22%) of the children reported to be a close
household contact of an adult with pulmonary tuberculosis
were placed on isoniazid prophylactic therapy and 7 of. .
these children were said to have completed 3 months of
prophylactic therapy. One child, on completion of 3 months'
isoniazid therapy, was tuberculin tested and given a repeat
BCG vaccination.
BCG vaccination
Discussion
In South Africa BCG vaccination of newborns was made
compulsory in 1973 when Japanese BCG strain 172 (Tokyo)
was introduced, administered by multiple puncture
percutaneous device. This BCG strain is derived from
Pasteur Institute seed culture taken to Japan by Kyoshi
Shiga in 1925 and maintained there by serial subculture on a
potato bile medium. After the 172nd transfer, a freeze-dried
lot now known as strain 172 was prepared, and the first
WHO reference preparation of BCG was obtained from this
freeze-dried lot.'·
Evaluated in South Africa shortly after its introduction, this
strain gave satisfactory levels of tuberculin conversion in
53% of individuals compared with 45% with the previously
used Glaxo BCG, also administered by multiple puncture.
Intradermal injection of the Japanese vaccine, however,
gave better tuberculin conversion results in 77% of those
evaluated."
Unfortunately tuberculin hypersensitivity does not
necessarily reflect protection against disease and in a British
Medical Research Council trial equal degrees of protection
resulted from two vole vaccines, only one of which induced
tuberculin hypersensitivity."
Evaluation of records at Boksburg-Benoni Hospital
between 1971 and 1976, during which period neonatal BCG
vaccination with the Japanese strain was introduced, noted
a marked decline in deaths from TBM and miliary
tuberculosis; this decline was associated with the
introduction of neonatal vaccination.,g When the presence of
a BCG scar was accepted as evidence of efficacious
vaccination, a subsequent study in the Pretoria area also
found a considerable protective effect.'o No formal controlled
trial of the currently used vaccine administered by multiple
puncture device has, however, been carried out.
Retrospective analysis of the use of strain 172 (Tokyo) in
Indonesia and Colombia did suggest a significant protective
effect."
In addition to the above studies, BCG vaccination by
percutaneous multiple puncture gave satisfactory tuberculin
conversion when evaluated in the UK," while formal trials of
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Fig. 1. Percentage of children at stage "' of tuberculous
meningitis relative to age at presentation.
of children under 12 months of age were at stage III TBM,
44% of those aged 24-36 months and only 19% of those
over 60 months of age were at stage III TBM on admission.
50
The assessment of the BCG status of the children is
summarised in Table I. In 143 children (74%) BCG
vaccination was confirmed either by annotation thereof on a
'Road to Health' card or by contact with the relevant local
authority clinic. In a further 18 children a BCG scar was
visible. BCG vaccination had therefore been given to at least
161(83%) children. A BCG scar could be detected in only
54 (38%) of the 143 children confirmed to have received
BCG and who were evaluated for the presence of a scar.
Evidence for the fading of the BCG scar is provided by the
fact that of the 59 children under 24 months of age at the
time of admission who were confirmed to have received
BCG, 32 (54%) had a scar still visible, as opposed to only
22 (32%) of the 67 children who were 24 months or older at
the time of admission.
BCG vaccination confirmed BCG vaccination not confirmed
(N = 143) (N = 50)
Scar Scar Scar Scar Scar Scar
assessed present absent assessed present absent
133 (93%) 54 (41 %) 79 (59%) 39 (78%) 18 (46%) 21 (54%)
Seventy-seven children (40%) had had close household
contact with at least one adult who had been treated for
pulmonary tuberculosis within the previous 2 years. Of the
84 children aged less than 24 months, 40 (48%) had had a
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percutaneous BCG vaccination in the USA showed a
protective effect in Chicago, but no protection in the
southern states.3 It should be noted that the 'immediate
households' of children studied in Chicago were, in
accordance with Calmette's suggestions, free of
tuberculosis at the time of vaccination." Many children in the
Western Cape may be exposed to tuberculous infection of
varying intensity shortly after vaccination.
Very few complications, in particular regional
lymphadenitis, are experienced in South Africa after BCG
vaccination. While this is welcomed and may be the result of
ease of administration by the percutaneous puncture
method, it has been suggested that the absence of
complications in the neonate may reflect an inadequately
protective dose." Again this factor has never been assessed
in formal controlled trials.
Prevention of disseminated forms of tuberculosis such as
TBM and miliary tuberculosis is one of the main aims of
neonatal BCG vaccination. It is thus disappointing that the
majority of children with TBM seen at our hospital did in fact
receive BCG at birth or shortly afterwards. Furthermore
despite BCG vaccination being one of the most successfully
administered vaccines in the Western Cape, the incidence of
TBM was recently found to be 24,3/100 000, one of the
highest in the world!' and when 75 children from the
Western Cape with miliary tuberculosis were evaluated
recently 88% had evidence confirming BCG vaccination!6
While our findings cannot be taken to indicate that BCG
vaccination failed to influence the incidence of TBM they do
suggest reason for concern and a need for controlled trials
to evaluate alternative forms of BCG administration and the
possible value of different strains of BCG.
Isoniazid· chemoprophylaxis
There is no reason to doubt the efficacy of isoniazid
chemoprophylaxis if given for at least 6 months. The debate
is rather about its place in a national tuberculosis control
programme. It has therefore been stated that it is the
conventional wisdom that chemoprophylaxis has no role in
developing or high prevalence countries. Certainly a
preventive programme should have a very low priority in
such a country's overall tuberculosis control strategy.
Nevertheless it might be considered, if only for infected,
young, close contacts of infectious cases."
Until recently it was recommended that close contacts of
adult pulmonary tuberculosis\patients be placed on isoniazid
prophylaxis and that after 3 months a tuberculin test be
performed. If negative it was assumed that the child was
uninfected and that BCG vaccination should be
administered. If positive, 'treatment' would be continued for
a further 3 months. These recommendations are similar to
those of the American Thoracic Society!'
Of the 77 children (40%) who had a close household
contact with pulmonary tuberculosis only 17 (22%) were
prescribed prophylaxis and only 4 actually completed 3
months of unsupervised therapy. Only 1 child appears to
have received a second BCG at this point.
Although there is no way of knowing in how many children
unsupervised isoniazid chemoprophylaxis did prevent TBM
and miliary tuberculosis, our data and those relating to the
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occurrence of TBM and miliary tuberculosis in the Western
Cape referred to above, suggest that even when
unsupervised chemoprophylaxis is applied it is not
particularly successful. As approximately 17% of adult
pUlmonary tuberculosis patients in the Western Cape health
region'· are not completing their prescribed course of
therapy it should come as no surprise that isoniazid
chemoprophylaxis is not enthusiastically pursued by hard-
pressed local authority health personnel.
Given several established epidemiological facts and our
own data, a stepwise approach to supervised childhood
chemoprophylaxis might be considered.
Mortality from childhood tuberculosis is highest in children
under 1 year of age and declines rapidly thereafter. Arnold
Rich," before the availability of chemotherapy, quoted a
mortality rate from tuberculosis infection of 4 920/100 000 in
those under 1 year of age, this fell to 123/100 000 in those
over 1 year. In South Africa between 1970 and 1980 the
case fatality ratio as a result of tuberculosis was 7,1 % in
those under 1 year, 2,8% in those' 1 - 2 years and 1,1 % in
those 2 - 3 years of age.30
More than half of our TBM patients under 2 years of age
were at stage III disease and this proportion declined
progressively with age. Of those 5 years or older less than
20% were at stage III on admission.
Adults with 'smear-positive' cavitating pulmonary
tuberculosis are more likely to infect close contacts, and
infection in these contacts is more likely to proceed to
disease than is the case with those 'positive' for M.
tuberculosis on culture only.31
With the above in mind, and considering the enormous
workload imposed by adult pulmonary tuberculosis on the
local authority clinic system, a better targeted, incremental
approach to chemoprophylaxis for close child contacts of
adults with pulmonary tuberculosis might be considered;
supervised chemoprophylaxis should be prescribed for all
children under 1 year of age in close household contact with
an adult pulmonary tuberculosis patient whose sputum is
'smear positive' for acid-fast bacilli. Older children and those
in contact with pulmonary tuberculosis sufferers whose
sputum is not 'smear positive' should be offered
unsupervised isoniazid chemoprophylaxis as is frequently
the case at present.
Only when more than 75% of infants who qualify for
prophylaxis as set out above are being successfully 'treated'
would the scheme be extended to an older group or those
whose index cases are producing smear-negative but
culture-positive sputum.
This approach would help ensure that children most in
need of chemoprophylaxis did, in fact, receive it and permit
local authorities with sufficient resources to offer supervised
prophylaxis to older children where appropriate, without
depriving other child contacts of the possible benefits of
unsupervised isoniazid chemoprophylaxis.
This study was supported by the Medical Research Council.
We thank the medical superintendent of Tygerberg Hospital for
permission to publish and local authority clinic personnel from
throughout the Western Cape for considerable assistance in
retrieving missing data.
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A prospective study of iron
status in white and black
pregnant women in an
urban hospital
F. Guidozzi, R. Patel, A. P. MacPhail
Evaluation of the iron status (haemoglobin and ferritin _
concentrations, and percentage transferrin saturation) in a
prospective study of 65 pregnant women (55 white and 10
black) revealed that adequate maternal iron stores dUring
pregnancy cannot be maintained with prevailing dietary
patterns. Although 80,6% of the patients had nonnal'
indices in the first trimester, only 12,3% were nonnal ip the
third. Significant depletion of iron stores occurred in the
second trimester, but significant iron-deficient
erythropoiesis only occurred in the third trimester. Despite
the decline in iron status, iron deficiency anaemia was
only seen in 7 - 8% of the patients. Even after correction
for the haemodilution and increased transferrin
concentrations in pregnancy, over 70% of women had
depleted iron stores in the third trimester. No beneficial
effect on fetal birth weights was found on withholding of
maternal iron supplementation. This study clearly
demonstrated that white and urban black pregnant women
require iron prophylaxis to maintain iron stores.
S AfT Med J 1995; 85: 170-173.
Since the 1940s it has been apparent that the amount of
iron available from dietary sources during pregnancy could
not meet the additional demands placed upon maternal
stores by the fetus, placenta and the increased maternal red
blood cell mass,1 As a consequence, iron supplements were
widely prescribed to prevent the fall in haemoglobin
concentration known to occur in pregnancy, without any
regard for the individual patient's needs.' However, in 1978
Hemminki and Starfield3 questioned the value of this
practice after having reviewed trials of iron prophylaxis
which showed no evidence of benefit to either the mother or
the fetus. Since then numerous arguments have been put
forward, both in favour of and against this widely accepted
essential component of good antenatal care,' In South
Africa, iron deficiency has been shown to occur commonly
in pregnant Indians-' and coloured·-1o women, emphasising
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